Chemo patch for skin cancer shows promise in early trial
NCT ID NCT03646188
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tested a new way to deliver the chemotherapy drug doxorubicin directly into basal cell skin cancer using tiny dissolving needles on a patch. The goal was to find a safe dose and see if it could completely remove the cancer. The study included 13 adults with small, untreated skin cancers, but was stopped early.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BASAL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Center for Clinical and Cosmetic Research
Aventura, Florida, 33180, United States